Kinase inhibitors

The University of Manchester 2019. Kinase inhibitors. WO2019220101. [Patent].

Preview

PDF - Published Version Download (10MB) | Preview

Abstract

The present invention relates to certain 4-(substituted aniline)-2-(substituted piperidin-1-yl)pyrimidine- -carboxamide compounds which may be useful in the treatment or prevention of a disease or medical condition mediated through signalling of CaMK1 isoforms. For example, such compounds and salts thereof may be useful in the treatment or prevention of a number of different cancers, metabolic diseases including type-2 diabetes, and/or immune-mediated disorders.

Item Type:	Patent
Date Type:	Publication
Status:	Published
Schools:	Biosciences
Date of First Compliant Deposit:	15 June 2020
Last Modified:	15 Jun 2020 13:45
URI:	https://orca.cardiff.ac.uk/id/eprint/132361

Citation Data

Cited 13 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item